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ABSTRACT
Background: Generalized vitiligo is an acquired disorder in which depigmented macules result from the auto-
immune loss of melanocytes from the involved regions of skin. Generalized vitiligo is frequently associated with
other autoimmune diseases, particularly autoimmune thyroid diseases (Hashimoto’s thyroiditis and Graves’ dis-
ease), rheumatoid arthritis, adult-onset type 1 diabetes mellitus, psoriasis, pernicious anemia, systemic lupus
erythematosus, and Addison’s disease.
Methods: One hundred and thirty-three Japanese patients with generalized vitiligo were enrolled in this study
to investigate the occurrence of autoimmune diseases in Japanese patients with generalized vitiligo and their
families.
Results: Twenty-seven of the patients with generalized vitiligo (20.3%) had autoimmune diseases, particularly
autoimmune thyroid disease (sixteen patients, 12%) and alopecia areata (seven patients, 5.3%). Thirty-five pa-
tients (26.3%) had a family history of generalized vitiligo andor other autoimmune diseases. Familial general-
ized vitiligo was present in fifteen (11.3%), including four families with members affected by autoimmune disor-
ders. Twenty (15.0%) had one or more family members with only autoimmune disorders.
Conclusions: Among Japanese vitiligo patients, there is a subgroup with strong evidence of genetically deter-
mined susceptibility to not only vitiligo, but also to autoimmune thyroid disease and other autoimmune disor-
ders.
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INTRODUCTION
Generalized vitiligo is an acquired disorder character-
ized by progressive, multifocal patches of depig-
mented skin, overlying hair, and mucous membranes
resulting from the autoimmune loss of melanocytes
in the involved areas. Generalized vitiligo is the most
common hypopigmentation disorder, with a preva-
lence of approximately 0.4% in most populations,1-3
though in the Chinese population, it is lower, approxi-
mately 0.093%.4 Studies of generalized vitiligo pa-
tients from a number of populations around the world
have shown a strong epidemiological association with
several other autoimmune diseases, particularly auto-
immune thyroid disease, rheumatoid arthritis, adult-
onset type 1 diabetes mellitus, psoriasis, pernicious
anemia, systemic lupus erythematosus (SLE), and
Addison’s disease.5-18 The most prevalent autoim-
mune disease in patients with generalized vitiligo is
autoimmune thyroid disease (Hashimoto’s thyroiditis
and Graves’ disease), with a reported overall fre-
quency of 19.4% in Caucasian patients,3 7.4% in Japa-
nese patients,13 and 2.4-5.8% in Chinese patients.14,16
In the Caucasian population, family members are pre-
disposed to vitiligo itself, an autoimmune thyroid dis-
ease, pernicious anemia, Addison’s disease, SLE, and
probably inflammatory bowel disease.19 In Japan, it is
still uncertain whether Japanese family members
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Table　1　Demographics of 133 Japanese generalized vitili-
go patients
Patients
Mean age ± SD (years) 49.3 ± 19.8
Age range (years) 3-89
Gender (male : female) 57 : 76
Age (years)
<20 20
20-59 57
≥60 56
Mean age at onset ± SD (years) 41.2 ± 20.9
Range of ages at onset (years) 3-88
Age at onset (years)
<20 29
20-59 63
≥60 41
Mean duration ± SD (years) 8.2 ± 8.6
Duration range (years) 0-63
have a similar tendency, although affected persons
have a predisposed relationship between generalized
vitiligo and autoimmune disorders.13 The purpose of
this investigation was to study the occurrence of con-
comitant autoimmune diseases in Japanese patients
with generalized vitiligo and their families.
METHODS
The study protocol was approved by each institution’s
ethics committee, and signed informed consent was
obtained from each subject. One hundred and thirty-
three Japanese patients were enrolled in this study.
They were diagnosed with generalized vitiligo at the
Dermatology Clinic of Kinki University, Osaka City
University, and Yamagata University.
The diagnosis of generalized vitiligo was deter-
mined by board-certified dermatologists (N.O., F.K.,
and T.S.) using standard diagnostic criteria; patients
with segmental and localized types of vitiligo were ex-
cluded. Subjects were questioned about the age at on-
set, the duration of the disease, and the personal and
familial medical history of generalized vitiligo, auto-
immune thyroid diseases, rheumatoid arthritis, type 1
diabetes mellitus, psoriasis, pernicious anemia, SLE,
Addison’s disease, alopecia areata, and other autoim-
mune diseases. Multi-specialist medical evaluations
were carried out to confirm the diagnoses in some pa-
tients and family members.
RESULTS
The characteristics of the one hundred and thirty-
three patients are summarized in Table 1. Of these
patients, twenty-seven (20.3%) had been diagnosed
with other autoimmune disorders (Table 2). Sixteen
(12%) had autoimmune thyroid disease, including
Hashimoto’s thyroiditis in ten (7.5%) and Graves’ dis-
ease in six (4.5%). Three (two males and a female)
had preceding Sutton’s nevus. Fifteen (11.3%) re-
ported a positive family history of generalized vitiligo
(Table 3), including four families with members af-
fected by autoimmune disorders. Seven (5.3%) had at
least one first-degree relative (parent or child) with
vitiligo, and four of these (3.0%) had at least one af-
fected sibling. Twenty (15.0%) had a family history of
only autoimmune disorders (Table 3).
DISCUSSION
We assessed the occurrence of autoimmune diseases
in one hundred and thirty-three Japanese patients
with generalized vitiligo. Generalized vitiligo is asso-
ciated with higher prevalence of other autoimmune
diseases in both the patients and their close rela-
tives.8,11,13-18 In the present study, twenty-seven pa-
tients (20.3%) with generalized vitiligo had other auto-
immune disorders. These results are similar to those
for other populations,5-12,15 including the Chinese and
Japanese populations.13,14,16 Seven patients (5.3%)
also had alopecia areata, a ratio that is similar to that
for generalized vitiligo patients in the African,20 In-
dian,21 and Chinese populations,14,22 though not in
the Caucasian population.8 Thirty-five patients (26.3%)
had a positive family history of generalized vitiligo or
other autoimmune diseases, which is again similar to
the ratio reported in other populations,8,23 suggesting
that these disorders involve shared susceptibility
genes, although the specific genes and variants may
differ among the populations.24-28
Recent genomewide association studies have iden-
tified at least seventeen confirmed vitiligo susceptibil-
ity genes.24-28 Many of these genes have also been
implicated in other autoimmune diseases, particularly
those that are epidemiologically associated with gen-
eralized vitiligo, such as autoimmune thyroid disease,
rheumatoid arthritis, type 1 diabetes mellitus, and
others. These shared immune related disease suscep-
tibility genes may underlie our observed associations
in patient with generalized vitiligo and their close
relatives.
Hashimoto’s thyroiditis is a fairly common disease
in Japanese generalized vitiligo patients as shown in
this study. This disease is characterized by the de-
struction of thyroid cells by various cell- and
antibody-mediated immune processes.29 However,
the initiating process is not well understood to date,
because it includes various environmental factors and
inflammatory events. Recent epidermological find-
ings5-18 including ours and genomewide association
studies24-28 support the long-standing hypothesis that
generalized vitiligo involves genetic susceptibility loci
shared with other autoimmune diseases.30 Similar to
autoimmune thyroid disease, generalized vitiligo is
now believed to be caused by the damage of melano-
cytes by various cell- and antibody-mediated immune
mechanisms. Nevertheless, the initiating process has
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Table　2　Autoimmune diseases in patients with generalized vitiligo
Number of patients Number of patients
total male female total male female
Autoimmune thyroid disease 16  5 11
Hashimoto’s thyroiditis 10 2 8
Graves’ disease  6 3 3
Alopecia areata  7  3  4
Psoriasis  2  2  0
Pernicious anemia  1  1  0
Adult-onset type 1 diabetes mellitus   (1†)   (1†)  0
Acrodermatitis continua of Hallopeau  1  1  0
Total 27 12 15
†The patient also had Graves’ disease.
Table　3　Occurrence of autoimmune diseases in families of 
generalized vitiligo
Number of 
families
Number of 
families
Positive family history of gen-
eralized vitiligo
15
Family member(s) with only 
generalized vitiligo
11
Family member(s) with gener-
alized vitiligo and other family 
member(s) with rheumatoid 
arthritis
 3
A family member with general-
ized vitiligo and another family 
member with aropecia areata
 1
Positive family history of only 
autoimmune disorders
20
Autoimmune thyroid disease 13
Hashimoto’s thyroiditis 5
Graves’ disease 5
Unknown 3
Alopecia areata  4
Rheumatoid arthritis  1
Psoriasis  1
Adult-onset type 1 diabetes 
mellitus
 1
Total 35
not well been elucidated. Further study is needed to
identify the initiating factors inducting generalized
vitiligo, autoimmune thyroid disease and other auto-
immune disorders.
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